BREAKING
Dogwood Therapeutics (DWTX) Q4 Loss Narrows to $0.26, Beats Estimates 11 hours ago General Mills (GIS) Q3 EPS Misses by 12% at $0.64 as Revenue Falls 8% YoY to $4.44B 11 hours ago Star Equity Holdings Slips to a Loss in Q4 FY25; Revenue Surges 69% to $56.8M 11 hours ago Ovid Therapeutics (OVID) Swings to $0.06 EPS in Q4 FY25 11 hours ago Giftify, Inc. (GIFT) Narrows Loss Q4 EPS Estimates by 11.0% 11 hours ago Weibo Corporation (WB) Misses Q4 EPS Estimates 12 hours ago ADMA CEO Adam Grossman Sells 15,000 Shares at $15.16 Amid 125K Share Insider Selloff 12 hours ago AESI CEO Forfeits Shares at $13.60 as Six-Month Insider Selling Trend Reaches 582,124 Shares 12 hours ago Ulta Beauty CEO Kecia Steelman Surrenders 1,491 Shares at $535.72 in Tax Withholding Transaction 12 hours ago BLDR CEO Peter Jackson and 7 Executives Surrender $2.77M in Shares for Tax Withholdings 12 hours ago Dogwood Therapeutics (DWTX) Q4 Loss Narrows to $0.26, Beats Estimates 11 hours ago General Mills (GIS) Q3 EPS Misses by 12% at $0.64 as Revenue Falls 8% YoY to $4.44B 11 hours ago Star Equity Holdings Slips to a Loss in Q4 FY25; Revenue Surges 69% to $56.8M 11 hours ago Ovid Therapeutics (OVID) Swings to $0.06 EPS in Q4 FY25 11 hours ago Giftify, Inc. (GIFT) Narrows Loss Q4 EPS Estimates by 11.0% 11 hours ago Weibo Corporation (WB) Misses Q4 EPS Estimates 12 hours ago ADMA CEO Adam Grossman Sells 15,000 Shares at $15.16 Amid 125K Share Insider Selloff 12 hours ago AESI CEO Forfeits Shares at $13.60 as Six-Month Insider Selling Trend Reaches 582,124 Shares 12 hours ago Ulta Beauty CEO Kecia Steelman Surrenders 1,491 Shares at $535.72 in Tax Withholding Transaction 12 hours ago BLDR CEO Peter Jackson and 7 Executives Surrender $2.77M in Shares for Tax Withholdings 12 hours ago
ADVERTISEMENT
AlphaGraphs

Agilent Q1 Revenue Rises 7%, Net Income Declines

February 26, 2026 2 min read

Agilent Technologies Reports Mixed 1Q 2026 Financial Results

An analysis of recent data released via infographic on Agilent Technologies, Inc. (NYSE: A) reveals a detailed overview of the company’s financial performance for the first quarter of 2026. The results provide a mixed narrative, with the company achieving solid top-line revenue expansion while navigating profitability challenges on a GAAP (Generally Accepted Accounting Principles) basis compared to the same period last year. All comparisons provided are on a year-over-year basis.

Top-Line Growth and Segment Breakdown

For 1Q 2026, Agilent reported a total net revenue of $1,798 million, representing a 7.0% increase. The revenue generation was segmented across two key reporting divisions included in the data. The Agilent CrossLab segment generated $758 million in revenue, leading the growth with a 9% increase. Meanwhile, the Applied Markets segment recorded $361 million in revenue, marking a 7% rise over the prior year.

Geographic Performance Divergence

The data shows a distinct contrast in revenue performance across different geographic markets. Revenue from U.S. points of sale reached $678 million, showing modest growth of 1%. Revenue from non-U.S. points of sale, however, demonstrated far more significant strength, increasing by 12% to reach $518 million.

Profitability Metrics and Future Outlook

Despite the positive revenue momentum, bottom-line profitability metrics declined. Net income for the quarter fell by 4.1% to $305 million. Consequently, GAAP Earnings Per Share (EPS) also decreased, dropping by 3.6% to $1.07. Conversely, Adjusted (non-GAAP) EPS saw a modest expansion, rising 3.8% to $1.21. Looking forward, the company provided specific guidance. For the upcoming second quarter (2Q) of 2026, Agilent forecasts revenue growth of 7% to 9%. Furthermore, the company’s outlook includes a projection for full-year (FY) 2025 revenue growth ranging between 4% and 5.5%.

ADVERTISEMENT